Riskpilot← Back to searchSign inGet full accessExplane MedTech AB
ABIn liquidationOrg 5590366976Repair and maintenance of electrical equipment · NACE 3314Est. 20150 employees
Revenue 2019
SEK 174K
+85% vs 2018
EBITDA margin
93.1%
+82% vs 2018
Equity ratio
64.7%
Financial strength
Net profit 2019
SEK 126K
+83% vs 2018
| Revenue | SEK 174K | +85% |
| EBITDA | SEK 162K | +82% |
| Net profit | SEK 126K | +83% |
| Total assets | SEK 272K | +47% |
| Equity | SEK 176K | +47% |
| Employees | 0 | — |
Legal name
Explane MedTech AB
Org number
5590366976
Legal form
Aktiebolag
NACE code
3314 · Repair and maintenance of electrical equipment
Founded
24 november 2015
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva konsultverksamhet, utveckling, reparation och underhåll av medicintekniska produkter och därmed förenlig verksamhet
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 336 | 106 | 94 | 174 |
| Staff expenses | — | — | — | — |
| EBITDA | 257 | 100 | 89 | 162 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 257 | 100 | 89 | 162 |
| Net financials | — | −1 | — | — |
| Profit before tax | 257 | 100 | 89 | 162 |
| Tax | −57 | −22 | −20 | −36 |
| Net profit | 200 | 78 | 69 | 126 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 321 | 212 | 185 | 272 |
| Equity | 250 | 165 | 120 | 176 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 71 | 47 | 64 | 96 |
| Total debt | 71 | 47 | 64 | 96 |
EBITDA margin
93.1%
This company
15.8%
Market median
+489% vs market
20162019
Equity ratio
64.7%
This company
38.2%
Market median
+69% vs market
20162019
Return on equity
71.6%
This company
18.4%
Market median
+289% vs market
20162019
Net profit margin
72.4%
This company
8.1%
Market median
+794% vs market
20162019
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20162019
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-11-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
PM Liquidator | Liquidator | 2021 – 2022 |
PM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Explane MedTech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Mikael Kolare | Liquidator | 0 companies |
| Per Magnus Sundberg | Deputy Chief Executive Officer | 0 companies |
| Anna Catharina Fernlöf Blomgren | Deputy Board Member | 0 companies |
| Karin Jessica Sundberg | Deputy Board Member | 0 companies |
| Rolf Erik Anders Fernlöf | Chairman | 0 companies |